it is called esophageal cancer or cancer of the esophagus. A cancerous tumor can develop at any point along the esophagus.

BeiGene (NASDAQ:ONC) announced Tuesday that the U.S. Food and Drug Administration (FDA) approved its anti-tumor agent Tevimbra as a first-line therapy for certain patients with esophageal cancer as ...

According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...

New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet ...

Prof. Gaofeng Liang from Clinical Medical College and Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan University of Science and Technology Disclaimer ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

In April this year, Mujica admitted he was suffering from a malignant esophagus tumor for which he received radiotherapy. “It is extremely complex in my case because I have suffered from an ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

Tumor entities which will most likely benefit most in the near future from novel combination therapies are head and neck cancer, esophageal cancer, pancreatic cancer and breast cancer. In advanced ...

In participants with a PD-L1 Tumor Area Positivity of at least ... Tevimbra is also indicated for esophageal cancer as monotherapy in adults with unresectable or metastatic ESCC after prior ...

Cancers of the esophagus are uniquely challenging to treat, for two important reasons. First, esophageal cancers are relatively uncommon in the United States, and thus many clinicians will not have ...